跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BILASTINA SANDOZ 20 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BILASTINA SANDOZ 20 MG COMPRIMIDOS EFG
Approved
STANDARD
BILASTINA SANDOZ 20 MG COMPRIMIDOS EFG
Sandoz Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 1, 2021
Approval ID
8a8ef8def7a840a2
Company
Sandoz Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
8a8ef8def7a840a2
Drug Cima Aemps Name
BILASTINA SANDOZ 20 MG COMPRIMIDOS EFG
Register Number
86062
Holder Company Name
Sandoz Farmaceutica S.A.
Marketing Company Name
Sandoz Farmaceutica S.A.
Authorization Date
2021-07-01
Dosage Form
COMPRIMIDO
Dose
20 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sandoz Farmaceutica S.A.
Active Ingredients
BILASTINA
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 1, 2021
Approval ID
8a8ef8def7a840a2
Type
Standard
Back to CIMA-AEMPS Approvals